Related Experiment Video
Updated: Jan 8, 2026

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
Bacterial extracellular vesicle ssRNA prevents colorectal cancer progression via Piezo1
Takeshi Kondo1, Yasunori Takayama2, Yutaro Kumagai3
1Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8636, Japan.
Abstract:
Single-stranded RNA (ssRNA) can activate the mechanosensitive ion channel Piezo1 in the gut. However, its source and role in colorectal cancer (CRC) remain unclear. In the present study, we demonstrate that ssRNA within fecal extracellular vesicles (FEVs) derived from bacteria, particularly those susceptible to lysis by ursodeoxycholic acid (UDCA), can suppress CRC progression via Piezo1 activation. Gut-specific Piezo1-knockout mice developed more tumors following CRC induction. Similarly, Piezo1-deficient CRC cell lines exhibited increased proliferation with upregulated Wnt/β-catenin signaling. Mechanistically, Piezo1 activation downregulated the transcription factor Zfp281, decreasing the expression of its target gene Lgr5 and dampening Wnt/β-catenin signaling. Notably, oral UDCA administration enhanced FEV rupture, increasing luminal "naked" ssRNA and mitigating high-fat diet-induced CRC in vivo. These findings identify the bacterial ssRNA-Piezo1 axis as a potential therapeutic target in CRC.
Insights
Bacterial single-stranded RNA (ssRNA) in fecal extracellular vesicles suppresses colorectal cancer (CRC) by activating the Piezo1 channel. Ursodeoxycholic acid enhances this effect, offering a potential therapeutic strategy for CRC.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Single-stranded RNA (ssRNA) activates the Piezo1 channel in the gut.
- The source and function of ssRNA in colorectal cancer (CRC) are not well understood.
Purpose of the Study:
- To investigate the role of bacterial ssRNA within fecal extracellular vesicles (FEVs) in CRC progression.
- To explore the ssRNA-Piezo1 axis as a potential therapeutic target for CRC.
Main Methods:
- Utilized gut-specific Piezo1-knockout mice and Piezo1-deficient CRC cell lines.
- Analyzed the effect of ursodeoxycholic acid (UDCA) on FEV rupture and ssRNA release.
- Investigated the molecular mechanisms involving Zfp281 and Wnt/β-catenin signaling.
Main Results:
- Bacterial ssRNA in FEVs suppresses CRC progression through Piezo1 activation.
- Piezo1 deficiency in mice and cell lines led to increased tumor development and proliferation.
- Piezo1 activation downregulates Zfp281, reducing Lgr5 expression and Wnt/β-catenin signaling.
- UDCA treatment enhanced FEV rupture, increased luminal ssRNA, and mitigated CRC in a high-fat diet model.
Conclusions:
- The bacterial ssRNA-Piezo1 axis is a critical suppressor of CRC.
- UDCA enhances FEV rupture, increasing protective ssRNA and reducing CRC.
- Targeting the ssRNA-Piezo1 pathway presents a novel therapeutic avenue for colorectal cancer.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
06:39Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
Published on: September 1, 2023
Related Concept Videos
Cancer Cell Migration through Invadopodia
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
PI3K/mTOR/AKT Signaling Pathway
piRNA - Piwi-interacting RNAs
Cancer Prevention
Some...